Prescription Iron Supplements

FeRiva 21/7®

Replenish + Regenerate = Renew

Formulated for enhanced absorption and tolerability

  • Chelated Iron in the form of Ferrous asparto glycinate (Sumalate®)
    – Highly soluble, almost 3x more bioavailable than ferrous sulfate
  • Two iron absorption promoters:
    – Vitamin C (ascorbic acid) and Succinic acid
  • Folic acid and Vitamin B12 help red blood cell development and DNA synthesis1,2,3

Visit Website



*Most eligible patients will pay only $30 per fill, with a savings up to $60 every time you fill. Maximums to apply. For FeRiva 21/7® the maximum benefit is $60 per fill. Patient will be responsible for any additional money due.
FeRiva 21/7® contains L-methylfolate calcium. The L-methylfolate ([6S]-N5-methyltetrahydrofolic acid calcium salt) in FeRiva 21/7® is less than 1.0% D-isomer.
FeRiva 21/7® is a registered trademark of Avion Pharmaceuticals, LLC. All rights reserved.
Sumalate® is a registered trademark of Albion Laboratories, Inc., covered by one or more claims of U.S. Patent Nos. 6,716,814, 8,007,846, and 8,425,956.
Marketed by Avion Pharmaceuticals LLC, Alpharetta, GA 30022
REFERENCES: 1. Kamdi SP, Palkar PJ. Efficacy and safety of ferrous asparto glycinate in the management of iron deficiency anaemia in pregnant women. J Obstet Gynaecol. 2014; Early Online: 1–5. doi:10.3109/01443615.2014.930098. Accessed December 29, 2014. 2. Willems F, Boers G, Blom H, Aengevaeren W, Verheugt F. Pharmacokinetic study on the utilization of 5-methyltetrahydrofolate and folic acid in patients with coronary artery disease. Br J Pharmacol. 2004; 141:825–830. 3. Koury MJ, Ponka P. New insights into erythropoiesis: The roles of folate, vitamin B12, and iron. Annu Rev Nutr. 2004; 24:105–131.

WARNING: Accidental overdose of iron-containing products is a leading cause of fatal poisoning in children under 6. Keep this product out of reach of children. In case of accidental overdose, call a doctor or poison control center immediately.

FeRiva 21/7® is a multivitamin / multimineral prescription dietary supplement indicated for use in improving the nutritional status of patients with iron deficiency.

Important Safety Information

FeRiva 21/7® has not been tested in children. Dosing for elderly patients should begin at the lower end of the dosing range. Talk to your doctor or healthcare provider before taking FeRiva 21/7® if you have a known sensitivity to any of its ingredients. Because some medications may interact with FeRiva 21/7®, you should tell your doctor or healthcare provider about any medications you are taking, including antacids and antibiotics.

You should not take this product if you have ever been diagnosed with hemolytic anemia or an iron overload disorder such as hemochromatosis or hemosiderosis.

If you have certain forms of anemia associated with vitamin B12 deficiency (i.e., pernicious anemia), the folic acid contained in FeRiva 21/7® is not enough to treat your condition. Folic acid in doses above 1.0 mg daily can hide the symptoms of these anemias, so your doctor must rule them out before prescribing this product.

Once you begin the FeRiva 21/7® 28-Day Iron Supplement Regimen, take one red iron tablet daily for 21 days, followed by 1 purple inert tablet for 7 days, with or without food, or as prescribed by your doctor or healthcare provider. Do not exceed the recommended dose.

Some patients taking folic acid have reported allergic reactions. Contact your doctor or healthcare provider and discontinue use if you develop any unusual symptoms.

Keep this product out of reach of children. Accidental overdose of iron-containing products is a leading cause of fatal poisoning in children under six. Symptoms and side-effects of overdose may include abdominal pain, metabolic acidosis, decline or absence of urine production, nerve damage, coma, convulsions, death, dehydration, congestion of blood vessels, cirrhosis of the liver, low blood pressure, hypothermia, fatigue, nausea, vomiting, diarrhea, black or tarry stools, vomiting blood, rapid heart rate, high blood sugar, drowsiness, abnormal pale or bluish skin color, lack of energy, seizures and shock. In case of accidental overdose, call a doctor or poison control center immediately.

To report negative side effects, contact Avion Pharmaceuticals, LLC at 1-888-61-AVION or the FDA at 1-800-FDA-1088 or www.fda.gov/Safety/MedWatch.